• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒形成工艺对可吸入蛋白粉末特性及气溶胶性能的影响。

Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.

机构信息

College of Pharmacy , The University of Texas at Austin , 2409 West University Avenue, PHR 4.214 , Austin , Texas 78712 , United States.

Amgen , One Amgen Center Drive , Thousand Oaks , California 91320 , United States.

出版信息

Mol Pharm. 2019 Oct 7;16(10):4165-4180. doi: 10.1021/acs.molpharmaceut.9b00496. Epub 2019 Aug 26.

DOI:10.1021/acs.molpharmaceut.9b00496
PMID:31448924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6800019/
Abstract

Pulmonary delivery of biopharmaceuticals may enable targeted local therapeutic effect and noninvasive systemic administration. Dry powder inhaler (DPI) delivery is an established patient-friendly approach for delivering large molecules to the lungs; however, the complexities of balancing protein stability with aerosol performance require that the design space of biopharmaceutical DPI formulations is rigorously explored. Utilizing four rationally selected formulations obtained using identical atomization conditions, an extensive study of the effect of the particle formation process (spray drying or spray freeze-drying) on powder properties, aerosol performance, and protein stability was performed. Multiple linear regression analysis was used to understand the relationship between powder properties, device dispersion mechanism, and aerosol performance. Spray drying and spray freeze-drying, despite the same spraying conditions, produced powders with vastly different physical characteristics, though similar aerosol performance. The resulting regression model points to the significance of particle size, density, and surface properties on the resulting aerosol performance, with these factors weighing differently according to the device dispersion mechanism utilized (shear-based or impaction-based). The physical properties of the produced spray dried and spray freeze-dried powders have differing implications for long-term stability, which will be explored extensively in a future study.

摘要

生物制药的肺部给药可以实现靶向局部治疗效果和非侵入性的全身给药。干粉吸入器(DPI)输送是一种成熟的患者友好型方法,可将大分子递送至肺部;然而,平衡蛋白质稳定性与气溶胶性能的复杂性要求对生物制药 DPI 制剂的设计空间进行严格探索。利用四种通过相同雾化条件合理选择的制剂,广泛研究了颗粒形成过程(喷雾干燥或喷雾冷冻干燥)对粉末特性、气溶胶性能和蛋白质稳定性的影响。多元线性回归分析用于理解粉末特性、装置分散机制和气溶胶性能之间的关系。尽管喷雾条件相同,但喷雾干燥和喷雾冷冻干燥产生的粉末具有截然不同的物理特性,尽管气溶胶性能相似。所得回归模型指出了粒径、密度和表面特性对气溶胶性能的重要性,这些因素根据所使用的装置分散机制(基于剪切或基于冲击)而有不同的权重。所产生的喷雾干燥和喷雾冷冻干燥粉末的物理特性对长期稳定性有不同的影响,这将在未来的研究中进行广泛探讨。

相似文献

1
Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.颗粒形成工艺对可吸入蛋白粉末特性及气溶胶性能的影响。
Mol Pharm. 2019 Oct 7;16(10):4165-4180. doi: 10.1021/acs.molpharmaceut.9b00496. Epub 2019 Aug 26.
2
Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.制剂和吸入器参数对喷雾冷冻干燥伏立康唑颗粒分散性的影响。
Int J Pharm. 2020 Jun 30;584:119444. doi: 10.1016/j.ijpharm.2020.119444. Epub 2020 May 21.
3
Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.以甘露醇为可吸入微粒/纳米颗粒的先进共喷雾干燥抗生素作为干粉吸入剂用于靶向肺部给药的设计、表征和气溶胶分散性能建模
J Pharm Sci. 2014 Sep;103(9):2937-2949. doi: 10.1002/jps.23955. Epub 2014 Apr 16.
4
Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.用于靶向肺部递送的先进喷雾干燥微粒/纳米微粒甘露醇粉末作为干粉吸入器的设计、表征和气溶胶分散性能建模。
J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):81-93. doi: 10.1089/jamp.2013.1078. Epub 2014 Feb 6.
5
Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach.制剂因素对溶菌酶粉末气溶胶性能和稳定性的影响:系统方法。
AAPS PharmSciTech. 2018 Oct;19(7):2755-2766. doi: 10.1208/s12249-018-0980-9. Epub 2018 Feb 27.
6
Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.妥布霉素和阿奇霉素有机溶液先进喷雾干燥微粒/纳米微粒抗生素干粉用于肺部吸入气雾剂递送的物理化学表征和气溶胶分散性能
Eur J Pharm Sci. 2014 Feb 14;52:191-205. doi: 10.1016/j.ejps.2013.10.016. Epub 2013 Nov 9.
7
Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder.吸入用单克隆抗体干粉颗粒工程中稳定性限制因素的识别
J Pharm Sci. 2022 Feb;111(2):403-416. doi: 10.1016/j.xphs.2021.08.022. Epub 2021 Aug 26.
8
Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.万古霉素和克拉霉素多功能控释粒子的先进喷雾干燥设计、理化特性表征和干粉吸入气溶胶的气溶胶分散性能,用于靶向呼吸递药。
Int J Pharm. 2013 Oct 15;455(1-2):374-92. doi: 10.1016/j.ijpharm.2013.06.047. Epub 2013 Jun 29.
9
Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.设计、表征和喷雾干燥莫西沙星和氧氟沙星二棕榈酰磷脂酰胆碱(DPPC)微粒/纳米颗粒粉末的气溶胶化,用于肺部吸入气溶胶给药。
Int J Nanomedicine. 2013;8:3489-505. doi: 10.2147/IJN.S48631. Epub 2013 Sep 17.
10
Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.超声喷雾冷冻干燥法制备均匀甘露醇载体中纳米颗粒的气溶胶传递。
Pharm Res. 2013 Nov;30(11):2891-901. doi: 10.1007/s11095-013-1120-6. Epub 2013 Jul 27.

引用本文的文献

1
Dry Powder Inhalers for Delivery of Synthetic Biomolecules.用于递送合成生物分子的干粉吸入器。
Pharmaceuticals (Basel). 2025 Jan 27;18(2):175. doi: 10.3390/ph18020175.
2
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.
3
Promising brain biodistribution of insulin via intranasal dry powder for nose-to-brain delivery.胰岛素通过鼻内干粉进行鼻至脑递送时展现出良好的脑内生物分布。
Heliyon. 2024 Jun 26;10(13):e33657. doi: 10.1016/j.heliyon.2024.e33657. eCollection 2024 Jul 15.
4
Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.了解甘露醇对吸入用喷雾干燥蛋白质粉末物理稳定性和雾化的影响。
Int J Pharm. 2024 Jan 25;650:123698. doi: 10.1016/j.ijpharm.2023.123698. Epub 2023 Dec 9.
5
Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics.粒子工程技术在小分子和生物治疗吸入递送上的进展。
Pharm Res. 2022 Dec;39(12):3047-3061. doi: 10.1007/s11095-022-03363-2. Epub 2022 Sep 7.
6
Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study.载利福平前体脂质体肺部给药的载体效应:设计质量研究
Adv Pharm Bull. 2022 Mar;12(2):336-345. doi: 10.34172/apb.2022.032. Epub 2021 May 18.
7
A Quality by Design Framework for Capsule-Based Dry Powder Inhalers.基于胶囊的干粉吸入器的质量源于设计框架
Pharmaceutics. 2021 Aug 6;13(8):1213. doi: 10.3390/pharmaceutics13081213.
8
Understanding the Impact of Protein-Excipient Interactions on Physical Stability of Spray-Dried Protein Solids.了解蛋白质-赋形剂相互作用对喷雾干燥蛋白质固体物理稳定性的影响。
Mol Pharm. 2021 Jul 5;18(7):2657-2668. doi: 10.1021/acs.molpharmaceut.1c00189. Epub 2021 Jun 7.
9
Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae.吸入式复方尼氯硝唑-溶菌酶颗粒的研制与评价:一种广谱、适应患者的冠状病毒感染及后遗症治疗方法。
PLoS One. 2021 Feb 11;16(2):e0246803. doi: 10.1371/journal.pone.0246803. eCollection 2021.
10
Co-Amorphization of Kanamycin with Amino Acids Improves Aerosolization.卡那霉素与氨基酸的共无定形化改善了雾化效果。
Pharmaceutics. 2020 Jul 30;12(8):715. doi: 10.3390/pharmaceutics12080715.

本文引用的文献

1
Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis.通过微透析技术探索吸入型单克隆抗体在肺实质中的命运。
MAbs. 2019 Feb/Mar;11(2):297-304. doi: 10.1080/19420862.2018.1556081. Epub 2019 Feb 4.
2
Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches.药物和生物制药的喷雾干燥:关键参数和实验过程优化方法。
Eur J Pharm Sci. 2019 Jan 15;127:300-318. doi: 10.1016/j.ejps.2018.10.026. Epub 2018 Nov 11.
3
Formulation techniques for high dose dry powders.高剂量干粉制剂技术。
Int J Pharm. 2018 Aug 25;547(1-2):489-498. doi: 10.1016/j.ijpharm.2018.05.036. Epub 2018 May 17.
4
Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach.制剂因素对溶菌酶粉末气溶胶性能和稳定性的影响:系统方法。
AAPS PharmSciTech. 2018 Oct;19(7):2755-2766. doi: 10.1208/s12249-018-0980-9. Epub 2018 Feb 27.
5
Effects of Drying Process on an IgG1 Monoclonal Antibody Using Solid-State Hydrogen Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).固体态氘氢交换质谱分析(ssHDX-MS)研究干燥过程对 IgG1 单克隆抗体的影响。
Pharm Res. 2018 Jan 3;35(1):12. doi: 10.1007/s11095-017-2318-9.
6
How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions.糖类如何在固态及干燥过程中保护蛋白质(综述):与应激条件相关的稳定机制。
Eur J Pharm Biopharm. 2017 May;114:288-295. doi: 10.1016/j.ejpb.2017.01.024. Epub 2017 Feb 9.
7
Role of Buffers in Protein Formulations.缓冲剂在蛋白质制剂中的作用。
J Pharm Sci. 2017 Mar;106(3):713-733. doi: 10.1016/j.xphs.2016.11.014. Epub 2016 Nov 26.
8
Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds.用于模拟吸入化合物的沉积、肺表面积和肺液测量
Front Pharmacol. 2016 Jun 24;7:181. doi: 10.3389/fphar.2016.00181. eCollection 2016.
9
Pulmonary Delivery of Butyrylcholinesterase as a Model Protein to the Lung.将丁酰胆碱酯酶作为模型蛋白肺部给药至肺脏。
Mol Pharm. 2016 May 2;13(5):1626-35. doi: 10.1021/acs.molpharmaceut.6b00066. Epub 2016 Apr 5.
10
Formulation Design of Dry Powders for Inhalation.吸入用干粉剂的处方设计
J Pharm Sci. 2015 Oct;104(10):3259-88. doi: 10.1002/jps.24574. Epub 2015 Aug 21.